Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
INVO Bioscience (INVO)
NASDAQ:INVO
Holding INVO?
Track your performance easily
INVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.63 - $3.50
Previous Close$0.84
Volume125.26K
Average Volume (3M)1.25M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$942.93K
Total Debt (Recent Filing)$3.92M
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Nov 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.54
Shares Outstanding3,906,072
10 Day Avg. Volume6,234,154
30 Day Avg. Volume1,246,600
Standard Deviation0.28
R-Squared0.07
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-20.82
Price to Sales (P/S)0.58
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
INVO Bioscience News
PremiumCompany Announcements
INVO Bioscience Completes Merger with NAYA Biosciences
PremiumCompany Announcements
INVO Bioscience Risks Nasdaq Delisting Amid Stock Price Woes
PremiumCompany Announcements
INVO Bioscience Navigates Lease Assignment and Nasdaq Woes
Ownership Overview
―
Insiders
2.01% Mutual Funds
2.57% Other Institutional Investors
94.03% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INVO FAQ
What was INVO Bioscience’s price range in the past 12 months?
INVO Bioscience lowest stock price was $0.63 and its highest was $3.50 in the past 12 months.
What is INVO Bioscience’s market cap?
Currently, no data Available
When is INVO Bioscience’s upcoming earnings report date?
INVO Bioscience’s upcoming earnings report date is Nov 11, 2024 which is tomorrow.
How were INVO Bioscience’s earnings last quarter?
INVO Bioscience released its earnings results on Aug 14, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.62.
Is INVO Bioscience overvalued?
According to Wall Street analysts INVO Bioscience’s price is currently Overvalued.
Does INVO Bioscience pay dividends?
INVO Bioscience does not currently pay dividends.
What is INVO Bioscience’s EPS estimate?
INVO Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Bioscience have?
INVO Bioscience has 3,906,072 shares outstanding.
What happened to INVO Bioscience’s price movement after its last earnings report?
INVO Bioscience reported an EPS of -$0.62 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.319%.
Which hedge fund is a major shareholder of INVO Bioscience?
Currently, no hedge funds are holding shares in INVO
---
INVO Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.27%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
171.61%
Trailing 12-Months
Company Description
INVO Bioscience
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.
---
INVO Earnings Call
Q2 2023
0:00 / 0:00
---
INVO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Anixa Biosciences
―
Brainstorm Cell Therapeutics
―
Cyclacel Pharmaceuticals
―
ESSA Pharma
―
---